Logo

NEWS

« zurück zur News-Übersicht


Jul 08, 2013
Grant from Bavarian Research Foundation to Fund Research on PPI Inhibitors for Tumor Therapy

Munich, Germany, July 8, 2013 - Priaxon and the research group of Prof. Vollmar at the Department of Pharmacy, Center for Drug Research, Ludwig-Maximilians-University, Munich win grant from Bavarian Research Foundation to fund research on PPI inhibitors for tumor therapy.

Within the cooperation Priaxon will apply its proprietary small molecule PPI drug discovery platform PriaXplore® to identify, synthesize and optimize new chemical entities targeting protein-protein interactions of high relevance in oncology. The group of Prof. Vollmar will cover all biological and pharmacological aspects of the cooperational project portfolio, which contains already established as well as highly innovative approaches in targeting oncology-relevant PPIs.